A scientific statement from the American Heart Association was published in Circulation, with the purpose of providing a thorough review of available evidence on HIV-associated cardiovascular disease.
People with HIV and cardiovascular disease have higher levels of the interleukin-1 receptor antagonist and soluble regulator sIL-1R1 up to 10 years before the first myocardial infarction.
Individuals with moderate to very severe COPD and cardiovascular risk factors did not have an increased risk for all-cause mortality or major adverse cardiovascular event occurrence with the use of aclidinium.
The U.S. Food and Drug Administration is launching on April 25, 2019, its “Remove the Risk” campaign, aimed at promoting the safe disposal of unused opioids.
The number of potentially abused elders is staggering: in 2015, older adults — defined as people age 65 or above constituted nearly 15% of the US population — up by 1.6 million from 2014.
